Hexokinase Assay Kits

Assay Principle

Hexokinase (HK) catalyzes the first committed step of glycolysis, phosphorylating glucose to glucose-6-phosphate at the expense of ATP. A hexokinase assay typically couples this glucose phosphorylation to a secondary enzymatic reaction, most commonly oxidation of the resulting glucose-6-phosphate by glucose-6-phosphate dehydrogenase, which reduces NADP+ to NADPH. This NADPH generation can be monitored directly by UV absorbance at 340 nm, or coupled further to a chromogenic developer for a colorimetric readout around 450 nm. Both formats provide a continuous, kinetic measure of hexokinase activity, with the UV method offering a simpler, dye-free readout and the colorimetric method generally providing better sensitivity in complex biological matrices.

Protocol highlights and purchasing considerations

Protocol Highlights

Because this reaction commits glucose to intracellular metabolism, hexokinase activity is a widely used indicator of glycolytic flux and is studied extensively in cancer metabolism, where the HK2 isoform in particular is frequently upregulated to support the Warburg effect, as well as in diabetes and insulin resistance research. Kits are validated across tissue homogenates, cultured cells, and serum, with assay conditions typically requiring careful ATP and Mg2+ supplementation, since both are obligate cofactors for the hexokinase reaction. Because glucose-6-phosphate dehydrogenase activity itself varies across tissue types and sample preparations, protocols generally recommend confirming that this coupling enzyme is not rate-limiting in the assay system, particularly when comparing hexokinase activity across tissues with very different baseline metabolic profiles. Researchers working with isoform-specific hexokinase biology should also note that most activity kits measure total hexokinase activity rather than distinguishing between HK1, HK2, HK3, and glucokinase isoforms.

Assay Kit Purchasing Considerations

The UV-based and colorimetric detection formats used to measure hexokinase activity are the primary point of differentiation across suppliers, with the choice generally driven by required sensitivity and available plate reader capability rather than any fundamental difference in the underlying chemistry. For cancer metabolism studies focused on HK2 specifically, researchers should confirm whether isoform-selective inhibitors or antibody-based approaches are needed alongside a general activity kit, since total hexokinase activity assays cannot isolate the contribution of a single isoform on their own. Given that hexokinase activity is often profiled alongside other glycolytic enzymes such as phosphofructokinase or pyruvate kinase, selecting a supplier with a compatible panel of glycolysis-pathway kits validated on the same sample types can streamline broader flux studies. As with any activity assay, it's good practice to review the full protocol before deciding on a kit, since the manual often reveals practical details, such as incubation times, control requirements, and data analysis steps, that aren't captured in the product summary alone.